US Stock MarketDetailed Quotes

Coherus Oncology (CHRS)

Watchlist
  • 1.600
  • -0.060-3.61%
Close Jan 16 16:00 ET
  • 1.605
  • +0.005+0.29%
Post 20:01 ET
193.39MMarket Cap1.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Coherus Oncology (CHRS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
91.19%11.57M
-0.41%10.25M
229.25%7.6M
3.78%266.96M
171.30%248.3M
-91.88%6.05M
-82.46%10.3M
-92.88%2.31M
21.89%257.24M
101.81%91.52M
Operating revenue
91.19%11.57M
-0.41%10.25M
229.25%7.6M
3.78%266.96M
171.30%248.3M
-91.88%6.05M
-82.39%10.3M
-92.88%2.31M
21.89%257.24M
101.81%91.52M
Cost of revenue
36.35%3.72M
87.67%3.4M
84.36%2.65M
-26.06%117.55M
31.94%111.58M
-91.66%2.73M
-92.72%1.81M
-91.47%1.44M
126.86%158.99M
495.46%84.57M
Gross profit
136.23%7.85M
-19.18%6.86M
469.16%4.95M
52.07%149.41M
1,865.33%136.73M
-92.06%3.32M
-74.94%8.49M
-94.42%869K
-30.30%98.25M
-77.67%6.96M
Operating expense
3.99%52.18M
8.80%52.35M
-26.62%50.38M
-13.39%261.07M
24.08%94.13M
-32.07%50.18M
-29.67%48.11M
-17.59%68.66M
-24.23%301.45M
-8.21%75.86M
Selling and administrative expenses
-11.36%24.93M
-5.36%26.04M
-35.31%26.03M
-12.64%167.74M
45.20%71.86M
-41.67%28.13M
-39.05%27.52M
-18.15%40.23M
-3.26%192.02M
-7.70%49.49M
Research and development costs
23.58%27.25M
27.71%26.31M
-14.31%24.36M
-14.71%93.34M
-15.57%22.26M
-14.02%22.05M
-11.47%20.6M
-16.78%28.42M
-45.11%109.44M
-9.14%26.37M
Operating profit
5.38%-44.33M
-14.79%-45.49M
32.97%-45.44M
45.05%-111.67M
161.83%42.6M
-46.40%-46.86M
-14.71%-39.63M
-0.06%-67.79M
20.90%-203.2M
-33.81%-68.91M
Net non-operating interest income expense
17.76%-2.33M
43.94%-2.28M
31.05%-2.15M
33.01%-27.16M
-72.67%-18.34M
72.47%-2.83M
59.15%-4.06M
67.90%-3.12M
-24.84%-40.54M
-13.15%-10.62M
Non-operating interest expense
-17.76%2.33M
-43.94%2.28M
-31.05%2.15M
-33.01%27.16M
72.67%18.34M
-72.47%2.83M
-59.15%4.06M
-67.90%3.12M
24.84%40.54M
13.15%10.62M
Other net income (expense)
2.74%2.14M
125.99%2.9M
-93.48%187K
2,959.65%167.33M
134,628.68%173.54M
-7.50%2.08M
-790.35%-11.16M
66.03%2.87M
327.88%5.47M
-106.42%-129K
Special income (charges)
--0
--0
----
--163.96M
--176.59M
--0
---12.63M
--153.65M
--0
--0
-Less:Other special charges
----
----
----
--12.63M
--0
----
--12.63M
----
----
----
-Gain on sale of business
----
----
----
--176.59M
---57K
---1.09M
--24.09M
--153.65M
--0
--0
Other non- operating income (expenses)
2.74%2.14M
97.75%2.9M
-93.48%187K
-38.33%3.37M
-2,262.02%-3.05M
-7.50%2.08M
-9.28%1.47M
66.03%2.87M
43.09%5.47M
-106.42%-129K
Income before tax
6.47%-44.52M
18.21%-44.86M
30.33%-47.4M
111.96%28.51M
348.34%197.81M
-18.94%-47.6M
-27.95%-54.85M
10.16%-68.04M
18.33%-238.27M
-35.30%-79.65M
Income tax
0
0
0
0
0
0
0
0
-380K
0
Net income
-230.49%-35.53M
2,404.52%297.77M
-154.99%-56.57M
111.98%28.51M
36.35%-50.7M
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
Net income continuous Operations
6.47%-44.52M
18.21%-44.86M
30.33%-47.4M
111.98%28.51M
348.34%197.81M
-20.08%-47.6M
-27.95%-54.85M
10.16%-68.04M
18.46%-237.89M
-35.30%-79.65M
Net income discontinuous operations
-75.61%8.99M
717.15%342.63M
-105.37%-9.17M
----
----
--36.85M
--41.93M
--170.91M
----
----
Minority interest income
Net income attributable to the parent company
-230.49%-35.53M
2,404.52%297.77M
-154.99%-56.57M
111.98%28.51M
36.35%-50.7M
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-230.49%-35.53M
2,404.52%297.77M
-154.99%-56.57M
111.98%28.51M
36.35%-50.7M
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
Basic earnings per share
-244.44%-0.31
2,436.36%2.57
-153.85%-0.49
109.88%0.25
38.03%-0.44
78.05%-0.09
77.55%-0.11
194.79%0.91
32.71%-2.53
6.58%-0.71
Diluted earnings per share
-244.44%-0.31
2,436.36%2.57
-153.85%-0.49
109.88%0.25
38.03%-0.44
78.05%-0.09
77.55%-0.11
194.79%0.91
32.71%-2.53
6.58%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 91.19%11.57M-0.41%10.25M229.25%7.6M3.78%266.96M171.30%248.3M-91.88%6.05M-82.46%10.3M-92.88%2.31M21.89%257.24M101.81%91.52M
Operating revenue 91.19%11.57M-0.41%10.25M229.25%7.6M3.78%266.96M171.30%248.3M-91.88%6.05M-82.39%10.3M-92.88%2.31M21.89%257.24M101.81%91.52M
Cost of revenue 36.35%3.72M87.67%3.4M84.36%2.65M-26.06%117.55M31.94%111.58M-91.66%2.73M-92.72%1.81M-91.47%1.44M126.86%158.99M495.46%84.57M
Gross profit 136.23%7.85M-19.18%6.86M469.16%4.95M52.07%149.41M1,865.33%136.73M-92.06%3.32M-74.94%8.49M-94.42%869K-30.30%98.25M-77.67%6.96M
Operating expense 3.99%52.18M8.80%52.35M-26.62%50.38M-13.39%261.07M24.08%94.13M-32.07%50.18M-29.67%48.11M-17.59%68.66M-24.23%301.45M-8.21%75.86M
Selling and administrative expenses -11.36%24.93M-5.36%26.04M-35.31%26.03M-12.64%167.74M45.20%71.86M-41.67%28.13M-39.05%27.52M-18.15%40.23M-3.26%192.02M-7.70%49.49M
Research and development costs 23.58%27.25M27.71%26.31M-14.31%24.36M-14.71%93.34M-15.57%22.26M-14.02%22.05M-11.47%20.6M-16.78%28.42M-45.11%109.44M-9.14%26.37M
Operating profit 5.38%-44.33M-14.79%-45.49M32.97%-45.44M45.05%-111.67M161.83%42.6M-46.40%-46.86M-14.71%-39.63M-0.06%-67.79M20.90%-203.2M-33.81%-68.91M
Net non-operating interest income expense 17.76%-2.33M43.94%-2.28M31.05%-2.15M33.01%-27.16M-72.67%-18.34M72.47%-2.83M59.15%-4.06M67.90%-3.12M-24.84%-40.54M-13.15%-10.62M
Non-operating interest expense -17.76%2.33M-43.94%2.28M-31.05%2.15M-33.01%27.16M72.67%18.34M-72.47%2.83M-59.15%4.06M-67.90%3.12M24.84%40.54M13.15%10.62M
Other net income (expense) 2.74%2.14M125.99%2.9M-93.48%187K2,959.65%167.33M134,628.68%173.54M-7.50%2.08M-790.35%-11.16M66.03%2.87M327.88%5.47M-106.42%-129K
Special income (charges) --0--0------163.96M--176.59M--0---12.63M--153.65M--0--0
-Less:Other special charges --------------12.63M--0------12.63M------------
-Gain on sale of business --------------176.59M---57K---1.09M--24.09M--153.65M--0--0
Other non- operating income (expenses) 2.74%2.14M97.75%2.9M-93.48%187K-38.33%3.37M-2,262.02%-3.05M-7.50%2.08M-9.28%1.47M66.03%2.87M43.09%5.47M-106.42%-129K
Income before tax 6.47%-44.52M18.21%-44.86M30.33%-47.4M111.96%28.51M348.34%197.81M-18.94%-47.6M-27.95%-54.85M10.16%-68.04M18.33%-238.27M-35.30%-79.65M
Income tax 00000000-380K0
Net income -230.49%-35.53M2,404.52%297.77M-154.99%-56.57M111.98%28.51M36.35%-50.7M72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M
Net income continuous Operations 6.47%-44.52M18.21%-44.86M30.33%-47.4M111.98%28.51M348.34%197.81M-20.08%-47.6M-27.95%-54.85M10.16%-68.04M18.46%-237.89M-35.30%-79.65M
Net income discontinuous operations -75.61%8.99M717.15%342.63M-105.37%-9.17M----------36.85M--41.93M--170.91M--------
Minority interest income
Net income attributable to the parent company -230.49%-35.53M2,404.52%297.77M-154.99%-56.57M111.98%28.51M36.35%-50.7M72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -230.49%-35.53M2,404.52%297.77M-154.99%-56.57M111.98%28.51M36.35%-50.7M72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M
Basic earnings per share -244.44%-0.312,436.36%2.57-153.85%-0.49109.88%0.2538.03%-0.4478.05%-0.0977.55%-0.11194.79%0.9132.71%-2.536.58%-0.71
Diluted earnings per share -244.44%-0.312,436.36%2.57-153.85%-0.49109.88%0.2538.03%-0.4478.05%-0.0977.55%-0.11194.79%0.9132.71%-2.536.58%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -